Versus Systems Inc (VS) Stock News

Four European entities have formed a strategic partnership to develop and deploy sovereign AI inference chips in Europe. VSORA's Jotunn8 processor will be integrated into Scaleway's cloud infrastructure with ZML's software layer, supported by the Île-de-France Region, aiming to reduce Europe's dependence on imported advanced AI chips and establish a competitive European AI semiconductor ecosystem.

Mizuho analyst Ann Hynes raised her CVS Health price target to $115 per share, implying 13% upside from current levels. The article suggests CVS could see even greater upside potential, potentially reaching $150 per share if it achieves a valuation multiple similar to UnitedHealth Group, given its transformation into a diversified healthcare services company and expected double-digit earnings growth.

PAVS announced a $10 million registered direct offering of 50 million Class A ordinary shares at $0.20 per share. The offering is expected to close on June 16, 2026. Proceeds will be used for evaluating strategic acquisition opportunities in consumer products, wellness, fitness, lifestyle, and digital commerce sectors, as well as working capital and general corporate purposes.

DevvStream Corp. (NASDAQ:DEVS) surged 19.37% in pre-market trading to $0.55 after announcing a $6 million Series A Convertible Preferred Stock placement with EEME Energy SPV I, LLC. The company will invest $5 million in Southern Energy Renewables Inc. and use $1 million for working capital. Additionally, DevvStream terminated its equity line agreement with Helena Global Investment Opportunities I Ltd. to simplify its capital structure ahead of a planned business combination with XCF Global Inc., a sustainable aviation fuel producer.

CVS Health's dividend is sustainable despite the company pausing annual increases. With Q1 2026 operating cash flow of $4.2 billion and expected annual cash flow of at least $9.5 billion, CVS comfortably covers its $3.39 billion projected dividend payout (representing just over 20% of cash flow). The company's 2.89% dividend yield significantly exceeds the S&P 500 average, making it an attractive income investment with minimal risk of elimination.

H1, an AI-powered healthcare platform for identifying and engaging physicians, secured a $40M investment led by CVS Health Ventures. The funding follows successful collaborations between the companies, including an AI model that improved healthcare provider directory accuracy. H1 serves 85% of top 20 pharma companies and 9 out of 10 top health plans, and is on track to achieve above Rule of 40 profitability metrics in 2026.

VS Media Holdings Limited (NASDAQ: VSME), a digital creator network company, announced plans to enter the AI Smart Living sector to explore new growth opportunities. The company intends to leverage its existing media resources, creator networks, and brand communications capabilities to develop smart home products, AI-enabled lifestyle services, and intelligent community solutions. VS Media plans to establish international business platforms and pursue strategic partnerships, though the company cautions that the business remains in early planning stages with no guaranteed outcomes.

CVS Health stock has surged 24% over the past month following strong Q1 earnings that beat analyst expectations, with revenue up 6.2% to $100.4B and EPS up 62% to $2.30. The company raised full-year guidance and is benefiting from improved margins in its Aetna insurance segment and growth from Rite Aid store acquisitions. However, the company carries significant debt of $86.4B in long-term obligations, though it is gradually reducing overall leverage.

International small-cap stocks were hit hard during the Iran-U.S. war, dropping nearly 12% from late February through March due to energy shocks and geopolitical concerns. However, they have since rebounded strongly, recovering most losses. The Vanguard FTSE All-World Ex-US Small-Cap ETF (VSS) is highlighted as an attractive long-term buy opportunity, having gained 10% since March 30 and 12% year-to-date, as valuations remain depressed and fundamental growth drivers remain intact.

Vishay Intertechnology introduced four series of 3000 W transient voltage suppressors (TVS) in the new DFN6546A package with wettable flanks. The automotive-grade and industrial-qualified devices feature a compact 6.5 mm x 4.6 mm footprint with 0.88 mm profile, offering twice the power dissipation of comparable packages while reducing volume by up to 76%. Samples and production quantities are available now with 12-week lead times.